Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1992 Oct;66(4):614–618. doi: 10.1038/bjc.1992.325

Active melanogenesis in non-S phase melanocytes in B16 melanomas in vivo investigated by double-tracer microautoradiography with 18F-fluorodopa and 3H-thymidine.

R Kubota 1, S Yamada 1, K Ishiwata 1, K Kubota 1, T Ido 1
PMCID: PMC1977418  PMID: 1419597

Abstract

3,4-Dihydroxy-2-[18F]fluoro-L-phenylalanine (2-[18F]FDOPA) and [6-3H]thymidine ([3H]Thd) were simultaneously injected into mice transplanted with B16 melanomas of FM3A mammary carcinoma. Melanogenesis was differentiated from DNA synthesis in the mitotic cell cycle by monitoring grain distribution with double-tracer microautoradiography. The percentages of pigmented cells were inversely proportional to those of [3H]Thd-labelled cells, indicating that the greater the number of melanocytes, the smaller was the number of proliferating cells. The number of grains produced by 2-[18F]FDOPA in the [3H]Thd-unlabelled melanocytes was significantly higher (P < 0.001) than the numbers in the [3H]Thd-labelled melanocytes and in nonmelanocytes. The [3H]Thd-unlabelled non-melanocytes and FM3A cells showed the lowest accumulation of 2-[18F]DOPA, which may have resulted from the basic amino acid demand by malignant neoplasms via amino acid transport. The [3H]Thd-labelled cells, regardless of whether they were pigmented or not, had slightly more grains with 2-[18F]FDOPA than the [3H]Thd-unlabelled non-melanocytes (P < 0.05), which may have resulted from the enhanced amino acid requirement for proliferation. Melanogenesis appeared to be activated only in the non-S phase of the mitotic cycle in melanocytes.

Full text

PDF
614

Images in this article

616Figure 2
on p.616

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett D. C. Differentiation in mouse melanoma cells: initial reversibility and an on-off stochastic model. Cell. 1983 Sep;34(2):445–453. doi: 10.1016/0092-8674(83)90378-1. [DOI] [PubMed] [Google Scholar]
  2. Bennett D. C. Mechanisms of differentiation in melanoma cells and melanocytes. Environ Health Perspect. 1989 Mar;80:49–59. doi: 10.1289/ehp.898049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ishiwata K., Ido T., Takahashi T., Iwata R., Brady F., Hatazawa J., Itoh M. Feasibility study of fluorine-18 labeled dopa for melanoma imaging. Int J Rad Appl Instrum B. 1989;16(4):371–374. doi: 10.1016/0883-2897(89)90102-5. [DOI] [PubMed] [Google Scholar]
  4. Ishiwata K., Kubota K., Kubota R., Iwata R., Takahashi T., Ido T. Selective 2-[18F]fluorodopa uptake for melanogenesis in murine metastatic melanomas. J Nucl Med. 1991 Jan;32(1):95–101. [PubMed] [Google Scholar]
  5. Jacobsohn G. M., Chiartas P. L., Hearing V. J., Jacobsohn M. K. Role of estradiol and 2-hydroxyestradiol in melanin formation in vitro. Biochim Biophys Acta. 1988 Aug 11;966(2):222–230. doi: 10.1016/0304-4165(88)90115-8. [DOI] [PubMed] [Google Scholar]
  6. Kreider J. W., Schmoyer M. E. Spontaneous maturation and differentiation of B16 melanoma cells in culture. J Natl Cancer Inst. 1975 Sep;55(3):641–647. doi: 10.1093/jnci/55.3.641. [DOI] [PubMed] [Google Scholar]
  7. Laskin J. D., Mufson R. A., Weinstein I. B., Engelhardt D. L. Identification of a distinct phase during melanogenesis that is sensitive to extracellular pH and ionic strength. J Cell Physiol. 1980 Jun;103(3):467–474. doi: 10.1002/jcp.1041030312. [DOI] [PubMed] [Google Scholar]
  8. Laskin J. D., Piccinini L., Engelhardt D. L., Weinstein I. B. Control of melanin synthesis and secretion by B16/C3 melanoma cells. J Cell Physiol. 1982 Dec;113(3):481–486. doi: 10.1002/jcp.1041130318. [DOI] [PubMed] [Google Scholar]
  9. Lejczak B., Duś D., Kafarski P. Phosphonic and phosphinic acid analogues of tyrosine and 3,4-dihydroxyphenylalanine (dopa) as potential antimelanotic agents. Anticancer Drug Des. 1990 Nov;5(4):351–358. [PubMed] [Google Scholar]
  10. Montefiori D. C., Kline E. L. Regulation of cell division and of tyrosinase in B16 melanoma cells by imidazole: a possible role for the concept of metabolite gene regulation in mammalian cells. J Cell Physiol. 1981 Feb;106(2):283–291. doi: 10.1002/jcp.1041060215. [DOI] [PubMed] [Google Scholar]
  11. Oikawa A., Nakayasu M., Claunch C., Tchen T. T. Two types of melanogenesis in monolayer cultures of melanoma cells. Cell Differ. 1972 Aug;1(3):149–155. doi: 10.1016/0045-6039(72)90024-3. [DOI] [PubMed] [Google Scholar]
  12. Oxender D. L., Lee M., Moore P. A., Cecchini G. Neutral amino acid transport systems of tissue culture cells. J Biol Chem. 1977 Apr 25;252(8):2675–2679. [PubMed] [Google Scholar]
  13. Pawelek J. M., Körner A. M. The biosynthesis of mammalian melanin. Am Sci. 1982 Mar-Apr;70(2):136–145. [PubMed] [Google Scholar]
  14. Prota G. Recent advances in the chemistry of melanogenesis in mammals. J Invest Dermatol. 1980 Jul;75(1):122–127. doi: 10.1111/1523-1747.ep12521344. [DOI] [PubMed] [Google Scholar]
  15. SEIJI M., SHIMAO K., BIRBECK M. S., FITZPATRICK T. B. Subcellular localization of melanin biosynthesis. Ann N Y Acad Sci. 1963 Feb 15;100:497–533. [PubMed] [Google Scholar]
  16. Saeki H., Oikawa A. Effects of pH and type of sugar in the medium on tyrosinase activity in cultured melanoma cells. J Cell Physiol. 1978 Feb;94(2):139–145. doi: 10.1002/jcp.1040940203. [DOI] [PubMed] [Google Scholar]
  17. Steinberg M. L., Whittaker J. R. Stimulation of melanotic expression in a melanoma cell line by theophylline. J Cell Physiol. 1976 Mar;87(3):265–275. doi: 10.1002/jcp.1040870302. [DOI] [PubMed] [Google Scholar]
  18. Turner J. H., Maziere M., Comar D. Localization of 11C-radiopharmaceuticals in the Greene melanoma of hamsters. Eur J Nucl Med. 1985;10(9-10):392–397. doi: 10.1007/BF00256577. [DOI] [PubMed] [Google Scholar]
  19. Yamada S., Kubota R., Kubota K., Ishiwata K., Ido T. Localization of [18F]fluorodeoxyglucose in mouse brain neurons with micro-autoradiography. Neurosci Lett. 1990 Dec 11;120(2):191–193. doi: 10.1016/0304-3940(90)90035-8. [DOI] [PubMed] [Google Scholar]
  20. van Langevelde A., van der Molen H. D., Journée-de Korver J. G., Paans A. M., Pauwels E. K., Vaalburg W. Potential radiopharmaceuticals for the detection of ocular melanoma. Part III. A study with 14C and 11C labelled tyrosine and dihydroxyphenylalanine. Eur J Nucl Med. 1988;14(7-8):382–387. doi: 10.1007/BF00254389. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES